How to Tell a Real GLP-1 Pen From a Counterfeit — Before You Inject It

The demand for GLP-1s created exactly the conditions counterfeiters look for: a scarce, expensive, brand-name injectable that people will buy from unfamiliar sellers online. The FDA has seized counterfeit semaglutide, and regulators have warned that fake pens have reached patients. Some of the fakes are convincing enough that you cannot tell by looking. So the answer is not "inspect harder" — it's "verify the source, then check the specific pen against the things counterfeiters get wrong."

Here's how to do both.

First, verify the seller — this catches most fakes before a pen ever ships

The overwhelming majority of counterfeit risk comes from where you bought it, not from a flaw you'll spot in your kitchen. Two free, authoritative databases settle the question fast:

• The NABP .pharmacy verification. The National Association of Boards of Pharmacy operates a program that vets legitimate online pharmacies. A verified pharmacy can use a .pharmacy domain, and NABP publishes a checkable list. If an online pharmacy selling brand-name GLP-1s is not on it, that is a reason to slow down.
• Your state board of pharmacy license lookup. Every U.S. pharmacy is licensed by a state board, and nearly all boards publish a searchable license database. A real pharmacy has a license number you can confirm.

If a website selling "Ozempic" won't tell you the licensed pharmacy that dispenses it, or the pharmacy it names isn't in either database, stop there. No pen inspection is needed — you've already found the problem.

I keep a step-by-step version of this check, with the direct database links, here.

Red flags in the listing itself

Before the pen even arrives, the sales page usually gives it away:

• No prescription required. Brand-name GLP-1s are prescription-only in the U.S. A site that sells them with no prescription and no clinician is operating illegally, which tells you everything about whether the product is real.
• "Generic Ozempic" or "generic Wegovy." There is no FDA-approved generic semaglutide pen. The brand is still under patent. Anything sold as a "generic" of the brand pen is either compounded (a different, non-FDA-approved product with its own rules) or counterfeit.
• Wildly low prices with wire-transfer or crypto-only payment. Legitimate pharmacies take normal payment and issue normal receipts.
• Overseas shipping of a U.S. brand pen. Personal importation of these is generally not legal, and it removes every verification layer the U.S. supply chain provides.

Checking the physical pen

If a pen is already in your hand, counterfeiters most often get these wrong:

• Lot number and expiration. Every real pen carries a lot number and expiration date, printed cleanly and matching between the pen and its carton. Fakes frequently have mismatched, missing, smudged, or impossibly-formatted lots. If a lot looks wrong, you can report it and ask the manufacturer to confirm whether that lot is authentic — manufacturers do maintain records of which lots they released. (Note the reverse is also true: a real-looking lot number alone does not prove authenticity, because counterfeiters copy real lots. Use it as one signal, not a verdict.)
• The label, print quality, and dose window. Real pens have crisp printing, correct fonts, and a clearly readable dose display. Blurry text, off-color packaging, misspellings, or a dose window that doesn't click cleanly between doses are warning signs.
• The medication itself. Real semaglutide and tirzepatide solutions are clear and colorless. Cloudy, particle-filled, or discolored liquid is a reason not to inject, full stop.
• The safety/tamper features. Missing seals, a carton that was clearly opened, or absent tamper-evidence all warrant stopping.

If you suspect a counterfeit — report it, don't just discard it

Two reports actually matter, and both are free:

1. The manufacturer, so they can confirm the lot and investigate the supply route.
2. The FDA's MedWatch program, which is how counterfeit and adverse-event signals reach regulators. Reporting a suspected fake — even one that didn't hurt you — is what lets the FDA trace and seize batches before they reach someone else.

Reporting takes a few minutes and is the single most useful thing an individual can do about counterfeits, because it's how the seizures upstream happen. The how-to, with the direct MedWatch link, is here.

The one-line version

You cannot reliably out-inspect a good counterfeit. You can reliably out-verify one: buy only from a pharmacy you confirmed in the NABP .pharmacy list or your state board's license database, require a real prescription, and treat "no prescription," "generic brand-name," and "crypto-only" as hard stops. Then check the lot, the print quality, and the clarity of the liquid before you inject.

A fuller field guide to spotting counterfeit Ozempic specifically — including what the current FDA warnings cover — is here.

The counterfeit problem is real and the fakes are improving. But the defense is boring and it works: verify the seller in a public database first, and no clever fake gets far enough to matter.

Verification methods and FDA/NABP program details current as of July 2026. If you suspect a counterfeit, contact the manufacturer and file a MedWatch report.